Oral migraine therapy effective in providing reliefAugust 12th, 2009 - 5:48 pm ICT by ANI
Washington, Aug 12 (ANI): A new investigational, orally inhaled therapy has been found effective in treating migraines, according to researchers.
The research team from Thomas Jefferson University Hospital in Philadelphia, Pennsylvania have shown that LEVADEX provided pain relief in 30 minutes and sustained relief for 48 hours.
The study participants reported significant relief from symptoms such as pain, nausea and light and sound sensitivity when compared to placebo treatment.
According to trial results, this therapy provided pain relief in 30 minutes and sustained relief for 48 hours after dosing in patients with moderate or severe migraine attacks.
The drug was generally very well tolerated and there were no drug-related, serious adverse events reported.
Migraine is a common, debilitating neurological disorder and common associated symptoms of migraine include nausea, vomiting, photophobia (sensitivity to light) and phonophobia (sensitivity to sound).
“The major advantage of LEVADEX is that it has the efficacy of intravenous DHE (dihydroergotamine) with a side-effect profile similar to placebo and better than oral triptans,” said Dr Stephen Silberstein, F.A.C.P, a clinical study investigator, director of the Jefferson Headache Center, and professor in the Department of Neurology at Jefferson Medical College of Thomas Jefferson University. (ANI)
- Aspirin could be the best remedy for migraine - Apr 14, 2010
- Exercise as good as drugs in staving off migraines - Oct 11, 2011
- Novel intranasal product highly effective in treating migraines - Apr 08, 2010
- Combination drug relieves migraine symptoms if taken early - Jul 08, 2008
- Ibuprofen may help people suffering from migraine headaches - Oct 06, 2010
- New nose spray quickly eases migraine - Dec 21, 2010
- 'Pain regulator gene' in brain could lead to new migraine painkillers - Sep 27, 2010
- Why light worsens migraine headaches? - Jan 11, 2010
- Now, cure migraine with a botox jab - Jan 19, 2012
- Coffee, aspirin best antidote to hangover - Jan 18, 2011
- Migraine likely to double risk of heart attacks - Feb 11, 2010
- Migraine 'doubles heart attack risk' - Feb 11, 2010
- Scientists identify faulty gene behind migraine - Sep 27, 2010
- Pelvic pain may lead to migraine in women - Dec 26, 2010
- Weight loss surgery can help alleviate migraines - Mar 29, 2011
Tags: dihydroergotamine, dr stephen, jefferson headache center, jefferson medical college, jefferson medical college of thomas jefferson universit, migraine, migraine attacks, migraine therapy, neurological disorder, philadelphia pennsylvania, placebo treatment, sensitivity to light, serious adverse events, side effect profile, sound sensitivity, stephen silberstein, study participants, thomas jefferson university, thomas jefferson university hospital, triptans